- Home
- MOGU vs EVAX Comparison
MOGU vs EVAX Comparison
Compare MOGU & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- EVAX
- Stock Information
- Founded
- MOGU 2011
- EVAX 2008
- Country
- MOGU China
- EVAX Denmark
- Employees
- MOGU N/A
- EVAX N/A
- Industry
- MOGU Business Services
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MOGU Consumer Discretionary
- EVAX Health Care
- Exchange
- MOGU Nasdaq
- EVAX Nasdaq
- Market Cap
- MOGU 19.8M
- EVAX 17.8M
- IPO Year
- MOGU 2018
- EVAX 2021
- Fundamental
- Price
- MOGU N/A
- EVAX $11.01
- Analyst Decision
- MOGU
- EVAX Strong Buy
- Analyst Count
- MOGU 0
- EVAX 2
- Target Price
- MOGU N/A
- EVAX $11.00
- AVG Volume (30 Days)
- MOGU 35.5K
- EVAX 4.6M
- Earning Date
- MOGU 11-21-2025
- EVAX 10-30-2025
- Dividend Yield
- MOGU N/A
- EVAX N/A
- EPS Growth
- MOGU N/A
- EVAX N/A
- EPS
- MOGU N/A
- EVAX N/A
- Revenue
- MOGU $19,462,964.00
- EVAX $3,176,000.00
- Revenue This Year
- MOGU N/A
- EVAX N/A
- Revenue Next Year
- MOGU N/A
- EVAX $425.50
- P/E Ratio
- MOGU N/A
- EVAX N/A
- Revenue Growth
- MOGU N/A
- EVAX 1042.45
- 52 Week Low
- MOGU $1.83
- EVAX $1.20
- 52 Week High
- MOGU $8.10
- EVAX $15.50
- Technical
- Relative Strength Index (RSI)
- MOGU 44.56
- EVAX 82.81
- Support Level
- MOGU $3.05
- EVAX $5.81
- Resistance Level
- MOGU $3.47
- EVAX $7.34
- Average True Range (ATR)
- MOGU 0.22
- EVAX 1.06
- MACD
- MOGU -0.08
- EVAX 0.48
- Stochastic Oscillator
- MOGU 14.42
- EVAX 87.23
About MOGU MOGU Inc.
MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.